05
Feb
2008
Posted in I - Series D, Q - 1Q08, R - NORTH EAST, X - Autoimmune Disease, X - Multiple Sclerosis
PeptImmune Inc. (Cambridge, MA) a clinical stage biotechnology company utilizing novel and proven technologies to improve the therapeutic management of chronic autoimmune and metabolic disorders such as pemphigus vulgaris and multiple sclerosis has closed on the first $8.2M traunche of a Series D financing. Participants include New Enterprise Associates, MPM Capital, Hunt Ventures, Boston Medical [...]
17
Jan
2007
Posted in I - Series A, Q - 1Q07, R - WEST, X - Autoimmune Disease
Proprius Pharmaceuticals (San Diego, CA) a drug developer focused on rheumatology and autoimmune diseases, has raised $11M in Series A funding led by Atlas Venture and joined by Forward Ventures, CDIB BioScience Venture Management along with return backers Fog City Fund and Windamere Venture Partners.